MedTrace Logo

Autogenic Relaxation and Murottal Therapy in Hemodialysis Patients

NCT07412548 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2026-02-17

No results posted yet for this study

Summary

This quasi-experimental study aims to evaluate the effect of combined autogenic relaxation and Surah Ar-Rahman murottal therapy on anxiety, sleep quality, and hemodynamic parameters in hemodialysis patients. A pretest-posttest control group design will be used involving 76 participants undergoing routine hemodialysis. Participants will be assigned to an intervention group receiving structured autogenic relaxation followed by murottal therapy and a control group receiving standard care with music listening. Anxiety, sleep quality, and hemodynamic parameters will be measured at baseline and after a 6-week intervention period. The findings are expected to support the use of non-pharmacological and spiritual-based interventions in improving psychological and physiological outcomes in hemodialysis patients.

Conditions

  • Chronic Kidney Disease Stage V
  • End-Stage Renal Disease
  • Hemodialysis

Interventions

BEHAVIORAL

Autogenic Relaxation and Surah Ar-Rahman Murottal Therapy

A structured non-pharmacological intervention consisting of autogenic relaxation techniques including breathing regulation, muscle relaxation, and self-suggestion, followed by listening to Surah Ar-Rahman murottal recitation using earphones. Each session lasts 10-15 minutes and is conducted twice weekly for six weeks during routine hemodialysis.

OTHER

listening to dangdut music

listening to dangdut music for 10 to 15 minutes within 6 weeks

Sponsors & Collaborators

  • Universitas Muhammadiyah Surakarta

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2026-05-31
Completion
2026-06-30

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07412548 on ClinicalTrials.gov